Stocks · Korea 001540 KOSDAQ

Ahn-gook Pharmaceutical

10,210원 +2.92% Market cap 1,332억 2026-10-07 close

📈 Chart & live quote

Data as of 2026-10-07 · Linked from 6 pages

An overview for this page is not available in English yet. The figures below are updated daily.

Key figures 2026-10-07 basis

PER15.52x

PBR0.70x

EPS658 KRW

BPS14,551 KRW

ROE9.49%

Dividend yield6.20%

DPS633 KRW

Payout ratio96.20%

Returns and 52-week range

1W+2.92%

1M-4.93%

3M+0.99%

6M+29.73%

1Y+27.31%

YTD+21.84%

52W high13,650원

52W low7,280원

From 52W high-25.20%

Financial results (consolidated)

Period	Revenue	Operating income	Net income	OP margin
2022	2,054억	97억	69억	4.7%
2023	2,337억	51억	10억	2.2%
2024	2,711억	67억	163억	2.5%
2025	3,069억	98억	73억	3.2%
Quarterly
2024 4Q	707억	12억	-7억	1.8%
2025 1Q	758억	59억	35억	7.7%
2025 2Q	768억	50억	31억	6.5%
2025 3Q	777억	49억	34억	6.3%
2025 4Q	766억	-59억	-26억	-7.7%
2026 1Q	989억	160억	124억	16.2%

Company

CEO어진, 박인철 (각자 대표)

Founded1959-02-12

Fiscal year end12

Websitewww.ahn-gook.com

Address: 경기도 과천시 과천대로7길 12 (갈현동) 프리즘스퀘어2 A동

Peers in the same sector

Company	Market cap	P/E	P/B	1M
삼성제약	1,350억	11.66	1.12	+7.82%
경보제약	1,315억	687.50	0.90	+1.48%
쎌바이오텍	1,431억	10.29	0.79	-3.91%
동성제약	1,249억	—	1.35	-8.82%
킵스파마	1,466억	—	2.36	+35.35%
코아스템켐온	1,245억	—	2.05	+7.78%

Recent filings

2026-08-14반기보고서 (2026.06)
2026-05-14분기보고서 (2026.03)

Source: DART (Financial Supervisory Service electronic disclosure)

Sources and notes

This page summarizes public filings, market data and news for information only. It is not a recommendation to buy or sell any security. Figures are as of the dates shown; check the original filings before making decisions.